(Q33187644)

23 July 2017

In vitro selection of viral vectors with modified tropism: the adeno-associated virus display (English)

1 reference

23 July 2017

0 references

8

Michael Hallek

1 reference

23 July 2017

Luca Perabo

1

1 reference

23 July 2017

Hildegard Büning

2

1 reference

23 July 2017

David M Kofler

3

1 reference

23 July 2017

Martin U Ried

4

1 reference

23 July 2017

Anne Girod

5

1 reference

23 July 2017

Clemens M Wendtner

6

1 reference

23 July 2017

Jörg Enssle

7

1 reference

23 July 2017

1 July 2003

1 reference

23 July 2017

1 reference

23 July 2017

8

1 reference

23 July 2017

151-157

1 reference

23 July 2017

1

1 reference

Identification of the Arg-Gly-Asp sequence in laminin A chain as a latent cell-binding site being exposed in fragment P1

23 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900123-0

7 January 2021

Selective growth response to IL-3 of a human leukaemic cell line with megakaryoblastic features.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900123-0

7 January 2021

Evolution of cell recognition by viruses

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900123-0

7 January 2021

Targeted adeno-associated virus vector transduction of nonpermissive cells mediated by a bispecific F(ab'gamma)2 antibody

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900123-0

7 January 2021

Acquired CD40-ligand deficiency in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900123-0

7 January 2021

Strategies to adapt adenoviral vectors for targeted delivery

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900123-0

7 January 2021

Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900123-0

7 January 2021

Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900123-0

7 January 2021

Incorporation of tumor-targeting peptides into recombinant adeno-associated virus capsids

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900123-0

7 January 2021

Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900123-0

7 January 2021

Retargeting gene delivery using surface-engineered retroviral vector particles.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900123-0

7 January 2021

AAV vectors: is clinical success on the horizon?

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900123-0

7 January 2021

Efficient and selective AAV2-mediated gene transfer directed to human vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900123-0

7 January 2021

Gene therapy: promises and problems.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900123-0

7 January 2021

Differential expression in human cells from the p6 promoter of human parvovirus B19 following plasmid transfection and recombinant adeno-associated virus 2 (AAV) infection: human megakaryocytic leukaemia cells are non-permissive for AAV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900123-0

7 January 2021

Modification of an adenoviral vector with biologically selected peptides: a novel strategy for gene delivery to cells of choice

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900123-0

7 January 2021

RGD and other recognition sequences for integrins

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900123-0

7 January 2021

Insertional mutagenesis of the adeno-associated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors targeted to alternative cell-surface receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900123-0

7 January 2021

MEC1 and MEC2: two new cell lines derived from B-chronic lymphocytic leukaemia in prolymphocytoid transformation

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900123-0

7 January 2021

Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900123-0

7 January 2021

Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900123-0

7 January 2021

The atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900123-0

7 January 2021

Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900123-0

7 January 2021

10.1016/S1525-0016(03)00123-0

Identifiers

DOI

1 reference

release_chsk2xlrnrfvrejoj67h3rsneq

23 July 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/chsk2xlrnrfvrejoj67h3rsneq

24 November 2022

mapped directly with Wikidata item

1 reference